中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2024-03-312023-12-312023-09-302023-06-302023-03-31
营业总收入(万元)599753.392281978.471701363.221116837.90549232.01
营业收入(万元)599753.392281978.471701363.221116837.90549232.01
营业总成本(万元)442578.231830411.461327456.80871251.84420304.73
营业成本(万元)94284.94352524.78265755.41176937.2285951.71
净利润(万元)136278.73431853.01348469.65232700.91122078.04
归属于母公司的净利润(万元)136892.92430243.59347377.92230826.50123910.75
营业利润(万元)163600.88490990.49394132.95257020.94134443.01
利润总额(万元)150251.08466710.97381237.69251244.52132474.87
少数股东损益(万元)-144.06-2461.52-2274.93-1785.92-571.50
基本每股收益(元)0.21(元)0.68(元)0.55(元)0.36(元)0.19(元)
稀释每股收益(元)0.21(元)0.68(元)0.55(元)0.36(元)0.19(元)
非经常性损益(万元)-7155.1016117.3211358.376496.591896.51
扣除非经常性损益后净利润(万元)144048.03414126.28336019.55224329.92122014.24
总资产(万元)4634000.144378450.664287139.074196133.334229383.00
总负债(万元)390064.60275142.02266480.46252546.82281974.59
归属于母公司股东权益合计(万元)4187350.484046579.543963690.063886060.733889181.01
股东权益合计(万元)4243935.534103308.644020658.613943586.513947408.41
实收资本(股本)(万元)637900.23637900.23637900.23637900.23637900.23
资本公积(万元)311256.51305763.90317114.43312028.95306998.75
未分配利润(万元)3017169.962880277.032797436.112680884.702675956.27
经营活动产生的现金流量净额(万元)125459.89764366.51430887.12287534.8521396.93
经营活动现金流入小计(万元)613605.142545507.241645626.991214524.91401691.40
经营活动现金流出小计(万元)488145.251781140.731214739.88926990.06380294.47
投资活动产生的现金流量净额(万元)-75039.02122231.51123758.6599820.7065992.51
投资活动现金流入小计(万元)1063.16272319.24261022.71198565.01104677.16
投资活动现金流出小计(万元)76102.19150087.73137264.0798744.3038684.66
筹资活动产生的现金流量净额(万元)-1813.46-314442.63-308994.30-262181.55-146480.10
筹资活动现金流入小计(万元)--2110.002110.001075.051000.00
筹资活动现金流出小计(万元)1813.46316552.63311104.30263256.59147480.10
期末现金及现金等价物余额(万元)2073939.022027152.431701364.771581688.081393649.17
最后修改日期2024-04-182024-04-182023-10-262023-08-212023-04-21
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。